Title:
PROTEIN KINASE DEGRADATION INDUCING COMPOUND, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/162493
Kind Code:
A1
Abstract:
The present invention relates to a protein kinase degradation inducing compound, and a use thereof. Particularly, the protein kinase degradation inducing compound of the present invention can degrade AURKA, FLT3 mutation, EGFR mutation, or c-KIT mutation proteins, and can, thereby, treat diseases related to AURKA, FLT3 mutation, EGFR mutation, or c-KIT mutation.
Inventors:
PARK JIN HEE (KR)
LEE YEONG DEOK (KR)
IM HYE RIM (KR)
KIM KYUN EUN (KR)
HWANG DONG KEUN (KR)
KO YI KYUNG (KR)
HAN AH REUM (KR)
NAM SU BEEN (KR)
KO EUN HWA (KR)
CHOI HWAN GEUN (KR)
KIM SUNG HWAN (KR)
LEE SUN HWA (KR)
BAE JAE HYUN (KR)
LEE YEONG DEOK (KR)
IM HYE RIM (KR)
KIM KYUN EUN (KR)
HWANG DONG KEUN (KR)
KO YI KYUNG (KR)
HAN AH REUM (KR)
NAM SU BEEN (KR)
KO EUN HWA (KR)
CHOI HWAN GEUN (KR)
KIM SUNG HWAN (KR)
LEE SUN HWA (KR)
BAE JAE HYUN (KR)
Application Number:
PCT/KR2021/001855
Publication Date:
August 19, 2021
Filing Date:
February 10, 2021
Export Citation:
Assignee:
VORONOI CO LTD (KR)
B2SBIO INC (KR)
B2SBIO INC (KR)
International Classes:
C07D498/22; A61K31/553; A61P3/04; A61P35/00
Domestic Patent References:
| WO2019060742A1 | 2019-03-28 |
Foreign References:
| US20170121321A1 | 2017-05-04 | |||
| US20190076539A1 | 2019-03-14 | |||
| US20190192668A1 | 2019-06-27 | |||
| US20150291562A1 | 2015-10-15 |
Attorney, Agent or Firm:
KIM, Kyeongkyo et al. (KR)
Download PDF: